Search

everythinglearnresearchcommunity

for

Search:↓

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Apremilast did not work for treating severe alopecia areata.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Combining PRP and microneedling effectively improves hair growth and patient satisfaction for hair loss.

Patients with lichen planopilaris have a higher risk of heart disease.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

STAT5 activation is crucial for starting the hair growth phase.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Red light and LED treatments help hair grow by activating a specific cell signaling pathway.

Temporary ROS production in cultured human hair follicles promotes growth and stem cell activation.

Patients with acne vulgaris have lower serum irisin levels.

Psoriasis patients should do moderate exercise like walking or yoga for 30 minutes, 4-5 times a week.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.